Bempeget-EZ™
Therapeutic Segment:
Cardiometabolic
Generic Name:
Bempedoic Acid + Ezetimibe
Indication
Tablets
- 180mg + 10mg
Bempeget-EZ Tablet is indicated in adults with primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia, as an adjunct to diet:
- In combination with a statin in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin, in addition to Ezetimibe.
- Alone in patients who are either statin-intolerant or for whom a statin is contraindicated, and are unable to reach LDL-C goals with Ezetimibe alone.
- In patients already being treated with the combination of Bempedoic Acid and Ezetimibe as separate tablets with or without statin.